Abstract
Coronavirus disease 2019 (COVID-19) is characterized by distinct patterns of disease progression that suggest diverse host immune responses. We performed an integrated immune analysis on a cohort of 50 COVID-19 patients with various disease severity. A distinct phenotype was observed in severe and critical patients, consisting of a highly impaired interferon (IFN) type I response (characterized by no IFN-β and low IFN-α production and activity), which was associated with a persistent blood viral load and an exacerbated inflammatory response. Inflammation was partially driven by the transcriptional factor nuclear factor-κB and characterized by increased tumor necrosis factor-α and interleukin-6 production and signaling. These data suggest that type I IFN deficiency in the blood could be a hallmark of severe COVID-19 and provide a rationale for combined therapeutic approaches.
Highlights
Ββααααα www.sciencemag.org (Page numbers not final at time of first release) 2 α κ α κ α β α αααββγ α α κ α αβ ω β α www.sciencemag.org (Page numbers not final at time of first release) 3 α α α αβ λ α κ α α α www.sciencemag.org (Page numbers not final at time of first release) 4
Β κ www.sciencemag.org (Page numbers not final at time of first release) 14
Summary
Ββααααα www.sciencemag.org (Page numbers not final at time of first release) 2 α κ α β α αααββγ α α αβ ω β α www.sciencemag.org (Page numbers not final at time of first release) 3 α α α αβ λ α www.sciencemag.org (Page numbers not final at time of first release) 4.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
